Related Experiment Video
Updated: Feb 20, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent
Wen-Qing Gao1, Jing Ma1, Liu-Liu Sun1
1Laboratory of Molecular Pharmacology, School of Pharmaceutical Sciences, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China.
Abstract:
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that is best known in mediating the toxicities of dioxins and dioxin-like compounds. AHR is activated by a variety of endogenous ligands and participating in tumor development. Thus, it will provide a new approach for cancer prevention and treatment to study the translation mechanism of AHR in tumor cells. In this study, we show that the 5'-untranslated region (UTR) of AHR mRNA contains an internal ribosome entry site (IRES). After mapping the entire AHR 5'-UTR, we determined that the full-length 5'-UTR is indispensable for the highest IRES activity. Interestingly, we found that AHR expression is induced in ovarian (A2780), breast (MDA-MB231), hepatic (Bel7402) and colorectal cancer cells (SW620) by chemotherapeutic drug paclitaxel (PTX) through IRES-dependent translation mechanism. Moreover, IRES activity is increased in the PTX-resistant ovarian cancer cells in which AHR protein expression was also enhanced. These results strongly suggest an important role for AHR IRES-dependent translation mechanism in cancer cell response to paclitaxel treatment.
Insights
The aryl hydrocarbon receptor (AHR) uses an internal ribosome entry site (IRES) for translation. This mechanism is key to how cancer cells respond to chemotherapy drugs like paclitaxel.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- The aryl hydrocarbon receptor (AHR) is a transcription factor involved in dioxin toxicity and tumor development.
- Understanding AHR's role in cancer cells offers new avenues for cancer prevention and treatment.
Purpose of the Study:
- To investigate the translation mechanism of AHR mRNA in cancer cells.
- To identify the role of AHR and its translation in response to chemotherapeutic agents.
Main Methods:
- Mapping of the AHR 5'-untranslated region (UTR) to identify functional elements.
- Analysis of AHR expression and internal ribosome entry site (IRES) activity in various cancer cell lines treated with paclitaxel (PTX).
- Comparison of IRES activity and AHR expression in paclitaxel-sensitive versus paclitaxel-resistant cancer cells.
Main Results:
- The 5'-UTR of AHR mRNA contains an internal ribosome entry site (IRES).
- Full-length AHR 5'-UTR is essential for maximal IRES activity.
- Paclitaxel (PTX) induces AHR expression in ovarian, breast, hepatic, and colorectal cancer cells via an IRES-dependent mechanism.
- Increased IRES activity and AHR protein levels were observed in PTX-resistant ovarian cancer cells.
Conclusions:
- AHR translation is regulated by an IRES-dependent mechanism.
- This IRES-dependent translation plays a significant role in cancer cell responses to paclitaxel treatment.
- Targeting AHR translation may offer novel therapeutic strategies for chemoresistant cancers.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Regulation of the Unfolded Protein Response
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps

